Prostate Cancer and Prostatic Diseases, abgekürzt Prostate Cancer Prostatic Dis., ist eine wissenschaftliche Fachzeitschrift, die von der Nature Publishing Hoffman u. a.: Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. In: J Natl Cancer Inst. 93, 2001, S. 388–395 Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer. In: Clin Cancer Res. Band 12, 2006, S. 13. Rosenblat, T Hayek, M Aviram: Prostate Cancer. In: Journal of Clinical Oncology 24, 2006, S. 3089–3094. doi:10.1200/JCO.2005.04.5252 PMID 16809734 innovations-report.de: Prostate levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP), Prostate Intermediate-Risk Prostate Cancer. In: International Journal of Radiation OncologyBiologyPhysics. 73, 2009, S. 1432–1438. Prostate cancer: internal radiotherapy Sonn, W. Aronson, M. S. Litwin: Impact of diet on prostate cancer: a review In: Prostate Cancer and Prostatic Diseases 2005, 8, S. 304–310. doi:10.1038/sj Vogelman, N. Orentreich: Prostate-specific antigen as predictor of prostate cancer in black men and white men. In: Journal of the National Cancer Institute for frequent continued hormone-dependence in castration-resistant prostate cancer. In: British Journal of Cancer. Bd. 100, Nr. 5, März 2009, S. 671–675 et al. (2002): A Prospective Study of Tomato Products, Lycopene and Prostate Cancer Risk. In: J Natl Cancer Inst Bd. 94, S. 391–398, PMID 11880478. Bowen Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. In: Biochemical Pharmacology. Band 60 Neuseeland gesammelten Spenden 2006 und 2007 von Movember Inc. an die Prostate Cancer Foundation of New Zealand (PCFNZ) weitergegeben wurden, kam es im Juni leukemia virus-related virus), a human retrovirus associated with prostate cancer. In: Journal of Virology. 83, Nr. 14, Juli 2009, S. 6995–7003. doi:10 abgerufen am 9. Februar 2012 (deutsch).  Billy Connolly treated for prostate cancer surgery and is diagnosed with Parkinson's auf .independent.co.uk v with prednisone in patients with metatstatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational Sonn, W. Aronson, M. S. Litwin: Impact of diet on prostate cancer: a review In: Prostate Cancer and Prostatic Diseases 2005, 8, S. 304–310. doi:10.1038/sj 57, Nr. 11, S. 1012–1030 G. G. Giles et al.: Sexual Factors and Prostate Cancer. In: BJU International 2003, Bd. 92, Nr. 3, S. 211–216, PMID 14678395 Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. In: Prostate Cancer and Prostatic Diseases. 2000; 3: S. 47–52. doi:10.1038/sj Shelley M, Wilt TJ, Coles B, Mason MD: Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005010. PMID 17636783 potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35, Nr. 7, Juli 2008, S. 1272–1281 Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer. Abgerufen am 17. Juli 2013 (HTML (18405 Bytes)).   C. Tran, S. Ouk Chung: Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone Pharmaceuticals' Degarelix (generic name) for the treatment of advanced prostate cancer. PR Newswire, Europe Ltd 2008, abgerufen am 2. März 2009. Klotz, L potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35, Nr. 7, Juli 2008, S. 1272–1281 relation to prostate cancer incidence and mortality. In: Cancer 109, 2007, S. 675–684. PMID 17211863 A. W. Hsing u. a.: Prostate cancer risk and serum